Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Talphera, Inc
- Study ID
- NCT06150742
- Status
- Recruiting
Conditions
- Acute Kidney Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Niyad (nafamostat mesylate) — DEVICENiyad (nafamostat mesylate) lyophilized
- Placebo (0.9% NaCl) — DEVICE0.9% NaCl
Study Details
A prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at higher risk for bleeding.
Key Dates
- Start date
- Aug 15, 2024
- Status verified
- Oct 2024
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Niyad1 mg/mL infusion of nafamostat mesylate
- Placebo Comparator: Placebo0.9% saline infusion
Primary Outcome Measure
mean post-filter activated clotting time (ACT) [ Time Frame: 24 hours ]
Central Contacts
- Nazneen Patel647-724-5709
- Chris Houchins
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California Los Angeles | Los Angeles | California | 90095 | Senior Clinical Research Associate |
| AdventHealth | Orlando | Florida | 32804 | Program Manager Study Intake |
| Henry Ford Health | Detroit | Michigan | 48202 | Clinical Study Coordinator |
| University of New Mexico | Albuquerque | New Mexico | 87131 | Nurse Research Coordinator |
| Northwell Health | Great Neck | New York | 11021 | Clinical Research Coordinator |
| Mount Sinai | New York | New York | 10029 | Clinical Research Assistant |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | Clinical Research Manager |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | Assistant Director, Laboratory Operations |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | Clinical Research Coordinator |
| Baylor University Medical Center | Dallas | Texas | 75246 | Research Nurse 1 |
Find similar trials in Los Angeles, CA
Related Studies
- Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric AKIEnrolling By Invitation · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
- Angiotensin 2 for AKI After OLTPHASE4 · Enrolling By Invitation · University of California, Los Angeles · Los Angeles, California
- Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn RegistryRecruiting · Potrero Medical · Los Angeles, California
- KIDney Injury in Times of COVID-19 (KIDCOV)Recruiting · University of California, San Francisco · San Francisco, California